We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...

Martin Grange, Trustee of Roy Castle Lung Cancer Foundation - and himself a lung cancer patient - also welcomed the news. He said: “Lung cancer takes up only 6% of the research funding spent on ...

Merck Sharp and Dohme’s P2X3 receptor antagonist Lyfnua (gefapixant) was backed for unexplained chronic cough, which was turned down by the FDA last year, but has also been approved in Japan and ...

If confirmed as health secretary, Robert F. Kennedy Jr. would oversee the Food and Drug Administration and other agencies ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at Leerink Partners believe that Merck’s Winrevair “should have ...

The authors write "Suboxone is the brand name of combination of Buprenorphine and Naloxone, manufactured by Indivior, Inc., ...

Tuberculosis Pipeline Report Introduction 2. Tuberculosis Pipeline Report Executive Summary 3. Tuberculosis Pipeline: ...

RAHWAY, N.J. & NUTLEY, N.J., January 24, 2025--Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Business Wire • yesterday Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and ...

DelveInsight’s, “Squamous Cell Carcinoma Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ ...

LONDON—Did you know that Mick Sharp, senior vice president, global operations and intelligence at Crisis24 (a GardaWorld company), enjoys travelling, wildlife, motorbikes and rugby, or that he’s ...

He pledges not to. Now she turns to his affiliation with a law firm that is suing Merck over its human papillomavirus vaccine. Apoorva Mandavilli Kennedy, after being pressed about whether he had ...